The pulse oximeter market share is estimated to be valued at USD 4,236.5 Mn in 2025 and is expected to reach USD 7,312.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

To learn more about this report, Download Free Sample
The pulse oximeter market demand is expected to be driven by factors such as the rising incidence of respiratory diseases, increasing awareness related to timely diagnosis of chronic illnesses, and the growing demand for home healthcare devices. Technologies advancements have allowed manufacturers to develop versatile pulse oximeters with features including exceptional accuracy, connectivity options, and compact sizes making them popular for use at home as well. Furthermore, there is additional demand for pulse oximeters for self-monitoring of blood oxygen levels at home amid the hospital capacity challenges posed by the virus.
|
Current Events |
Description and its Impact |
|
Healthcare Policy Shifts |
|
|
Geopolitical Trade Disruptions |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The integration of artificial intelligence into pulse oximeter market is optimizing the accuracy and reliability of oxygen saturation measurements, especially in challenging situations like low saturation levels or darker skin tones. AI algorithms have the potential to analyze pulse oximeter data to compensate for factors like motion artifacts, skin tone variations, and signal degradation, leading to more precise readings. This includes predicting oxygen needs, detecting anomalies, and potentially guiding automated oxygen delivery systems. Artificial intelligence (AI) offers improving the SpO2 monitoring by enabling more accurate, equitable, and accessible estimations.
In August 2024, EnsoData, an AI-driven healthcare innovator, formed a strategic alliance with Nonin Medical to introduce an affordable, non-invasive at‑home sleep apnea testing solution. The collaboration integrates the FDA-cleared EnsoSleep PPG algorithm with Nonin’s reusable WristOx 2® Model 3150 pulse oximeter, enabling sleep labs to diagnose obstructive sleep apnea remotely. The WristOx provides accurate continuous SpO₂ and pulse rate monitoring, even during patient movement or low perfusion, ensuring reliability.
In terms of product type, the tabletop pulse oximeters segment is estimated to hold 37.8% of the market share in 2025 owing to its continuously monitoring patients with respiratory illnesses. Tabletop pulse oximeters are designed for situations where a patient needs constant monitoring of their blood oxygen saturation levels. This is crucial for individuals with respiratory conditions such as COPD, or during surgical procedures where anesthesia is administered.
In May 2025, BPL Medical introduced its Cleo Plus tabletop pulse oximeter in India, featuring a 7‑inch TFT color LCD designed for use in clinical environments such as ICUs and hospital wards. The device offers continuous 24‑hour SpO₂ and pulse-rate monitoring, coupled with adjustable audible and visual alarms to alert medical staff of critical changes.
In terms of sensor type, the disposable sensors segment is estimated to hold 28.9% of the market share in 2025. A single-use attachments is disposed after each patient, resulting in elimination of any risks of cross-contamination between patients. This is a major advantage in hospital and clinical environments where a large number of patients are monitored on a daily basis. Disposable sensors also relieve users from the hassle of re-sterilization or cleaning of reusable devices between successive uses. Their convenience and the assurance of infection control drives consistent preference among healthcare facilities and practitioners.
In January 2024, Medical technology firm Inspira Technologies developed a single-use disposable blood oxygenation kit compatible with its INSPIRA™ ART life-support series, targeting hospitals and critical care settings. It is designed to streamline extracorporeal oxygenation by bypassing traditional ventilators, the kit aims to reduce hospital costs through a razor‑blade-style disposable business model. The company plans to submit for FDA clearance in 2025, broadening integration with cardiopulmonary bypass and other perfusion systems.
In terms of end user, the hospitals segment is estimated to hold 42.7% of the market share in 2025 owing to the criticality of pulse oximetry monitoring in acute care settings. Pulse oximetry finds immense utility in hospital departments such as emergency rooms, intensive care units, and operation theatres where constant evaluation of patients' oxygen saturation is imperative. Their non-invasive nature and quick readings ensure minimal disruptions to patient care. Additionally, the larger scale of operations in hospitals translates to higher volumes of pulse oximeter procurement. With oxygen saturation emerging as a vital sign parameter, demand from hospitals continues to accelerate as pulse oximetry becomes further engrained in standard protocols for diverse cases.
For instance, in June 2024, Charnock Hospital in Kolkata launched an Enhanced Patient Care Programme, equipping all ward beds with Dozee’s AI-powered, contactless vital monitoring system. The initiative enables real-time tracking of heart rate, respiratory rate, blood pressure, temperature, ECG—and importantly, SpO₂ levels, facilitating early detection of clinical deterioration through a live Early Warning System.

To learn more about this report, Download Free Sample
North America remains the dominant region in the global pulse oximeter market and is estimated to hold 38.6% of the market share in 2025. With a highly developed healthcare infrastructure and higher healthcare spending. The region is home to many leading pulse oximeter manufacturers such as Medtronic, Masimo, GE Healthcare, and Nonin Medical who have strong distribution networks across the country. Moreover, the presence of large pool of pulse oximeter users like hospitals, clinics, home healthcare providers, and individuals has continuously fuel demand in North America. For instance, MightySat Medical with Masimo SET® provides an FDA-cleared medical device with validated accuracy without the need for a prescription. SET®, available in numerous hospital devices, is the primary pulse oximetry technology in the U.S. hospitals.
The Asia Pacific region has emerged as the fastest growing market for pulse oximeter market in recent times. China and India are spearheading the market growth owing to rising population, increasing healthcare awareness, and improving access to healthcare facilities in rural regions. Both countries are witnessing higher incident of chronic diseases like COPD and cardiac problems due to growing geriatric population and changing lifestyle trends. An estimated 90% of COPD- related deaths occur in low/middle income countries. India and China together constitutes about one third of the total human population, accounting for 66% of COPD mortality globally. This has significantly boosted the sales of pulse oximeters. Furthermore, the governments of various APAC countries have recognized pulse oximetry as an essential device for critical care and are promoting its usage which is positively influencing the pulse oximeter market forecast.
The U.S. pulse oximeter market is driven by the due to a combination of factors including the prevalence of respiratory illnesses, and the increasing adoption of at-home health monitoring. There is a significantly raised awareness about the importance of monitoring blood oxygen levels, while pre-existing conditions like asthma and COPD continue to drive demand for these devices. According to the American Lung Association, more than 35 million people living in the U.S. have a chronic lung disease like asthma and COPD. This is further accelerating the pulse oximeter industry demand.
The China pulse oximeter market is experiencing significant growth due to the country’s aging population, the prevalence of respiratory and cardiovascular diseases. Along with that China is one of the prominent manufacturers of oxygen concentrators. Chinese companies have significantly increased production to meet international needs, with some companies reporting monthly production capacities of 50,000 units. Additionally, the Chinese Centre for Disease Control and Prevention (CDC) has reported a sharp increase in respiratory viral infections, including human metapneumovirus (hMPV) infections, in northern China since December 2024. Experts note that growing pulse oximeter market price inflation driven by this heightened demand may add €5–10 per unit, although it remains affordable compared to other medical devices. As domestic manufacturing scales and infection monitoring becomes more vital, China is positioned to lead in both production and innovation in pulse oximetry.
India continues to lead the adoption of pulse oximeter, driven by the increase in healthcare awareness, as the India Ministry of Health recommends home use of oximeter, which will offer early detection and triage at household level. Along with that, India has a rise in respiratory and cardiac illnesses which includes chronic obstructive pulmonary disease (COPD), asthma, and cardiac conditions, leading to greater demand for continuous oxygen saturation monitoring, particularly in older adults and high-risk patients. For instance, in July 2024, yashoda Super Specialty Hospital in Kaushambi introduced the SmartCare Monitoring Programme, integrating Dozee’s remote patient monitoring and Early Warning System across its facility. The system delivers continuous surveillance of multiple vital signs, including SpO₂, to preempt emergencies and bolster operational efficiency. This is further accelerating the pulse oximeter market demand in India.
As the number of people suffering from respiratory conditions like asthma, and pneumonia continues to rise globally, there is an increasing need for pulse oximeters to monitor patients' oxygen saturation levels. Pulse oximetry allows for remote, continuous monitoring of oxygen levels in blood which is extremely useful for the treatment and management of respiratory diseases. For instance, according to the World Health Organization (WHO) report published in March 2023, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths. Moreover, according to the same source, low- and middle-income countries (LMIC) account for about 90% of deaths from COPD in those under the age of 70. The pulse oximeter market value enhances remote, continuous monitoring, innovative wearable pulse oximeters presented at ATS 2025 are transforming obstructive sleep apnea diagnostic system, illustrating their impact across respiratory care platforms.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 4,236.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.1% | 2032 Value Projection: | USD 7,312.6 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Stryker, Medtronic, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc., Smiths Group plc, Honeywell International, Promed Technology Co., Ltd., Contec Medical Systems Co., Ltd., CONMED Corporation, Curbell Medical Products, Inc., Ecomed, Masimo, TytoCare Ltd., and BioIntelliSense, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
There is a marked shift towards remote patient monitoring and home healthcare globally as it enables cost savings, improved accessibility, and better management of chronic conditions. Pulse oximetry plays a critical role in facilitating remote monitoring of vitals and oxygen saturation levels especially for high-risk patients or those recovering from surgeries or illnesses. The ability of pulse oximeters to transmit readings electronically to doctors or caregivers has further increased their value in home care applications. Various players are also introducing more advanced, integrated devices that can measure and track multiple parameters besides oxygen saturation. Governments and insurance agencies are promoting home-based monitoring to avoid unnecessary hospitalizations. Even patients prefer remaining in familiar home settings under remote supervision. This rising prominence of home healthcare and focus on remote patient monitoring is catalyzing the uptake of pulse oximeters among households rather than just clinical settings. Various options available in different form factors, wearing formats and price points ensure wider accessibility and adoption.
According to recent pulse oximeter market research, Masimo announced in May 2025 the launch of its MightySat Rx device for remote home use, combining pulse oximetry with respiration rate and perfusion index tracking—signaling the growing trend of multifunctional home-use oximeters.
The integration of smartphones with pulse oximeters provides a great opportunity to revolutionize the global pulse oximeter market forecast, unlocking seamless remote SpO2 and heart rate monitoring. In today's connected world, most people own a smartphone which they use for multiple purposes on a daily basis. If pulse oximeter devices are able to directly communicate and pair with smartphones via applications or Bluetooth-enables apps allowing continuous health tracking making it ideal for patients with chronic respiratory illnesses or those in ICUs.
For instance, Viatom’s FDA-cleared Smart Ring O2Ring sends real-time readings to the ViHealth app, enabling 24/7 SpO₂ trends and alerts. With smartphone compatibility, pulse oximeters become more accessible, data-rich, and clinically valuable positioning them as central to future remote and home monitoring strategies.
*Definition: Pulse Oximeter is an electric device used to measure oxygen saturation in red blood cells. It can be attached to fingers, forehead, nose, foot, ears or toes for measuring the oxygen count in red blood cells. It is a noninvasive, rapid, and continuous method of monitoring oxygenation, allowing detection of sudden changes in a patient's clinical status. The amount of red and infrared light in an area of pulsatile blood flow can be measured by modern pulse oximeters. Pulse oximeter measures blood oxygen saturation (SpO2), pulse rate, perfusion index (PI).
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients